Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

Rapid reductions in prices for generic sofosbuvir and daclatasvir to treat hepatitis C

A study on how  generic competition can rapidly lower the prices of drugs with high hepatitis C cure rates, like sofosbuvir and daclatasvir and help achieve global treatment scale-up, 12th January, 2016

Click here for more details.

/ News

Share the Post